服務(wù)熱線(xiàn)：
Innovative Research/PAI-1 mutant stable no LRP binding/IHPAI-R76E-I91L/1.0mg
天然蛋白
商品編號
IHPAI-R76E-I91L
品牌
Innovative Research
公司
Innovative Research
公司分類(lèi)
Proteins
Size
1.0mg
商品信息
Product Description
PAI-1 mutant stable no LRP binding
A substitution of Glutamic Acid for Arginine at position 76 greatly decreases the binding of this Human PAI-1 mutant to the low density lipoprotein receptor-related protein (LRP). The putative LRP binding exosite is thought to overlap with the heparin binding site on the PAI-1 molecule. Binding to LRP or similar receptors leads to the clearance of PAI-1 complexes. An additional mutation (Isoleucine 91 to Leucine) provides increased st
ABI
lity for use in long term binding experiments or in vivo studies.
References:
產(chǎn)品貨號：16179.2
Innovative Research/Human PAI-1 N-terminal cysteine mutant, latent fraction/INTCYSPAI-L/0.5mg
Innovative Research/Human PAI-1 N-terminal cysteine mutant, latent fraction/INTCYSPAI-L/1.0mg
Innovative Research/Human PAI-1 N-terminal cysteine stable mutant/INTCYSCPAI/0.5mg
Innovative Research/Human PAI-1 N-terminal cysteine stable mutant/INTCYSCPAI/1.0mg
Innovative Research/Human PAI-1 N-terminal cysteine, active fraction/INTCYSPAI-A/0.5mg
Innovative Research/Human PAI-1 N-terminal cysteine, active fraction/INTCYSPAI-A/1.0mg
Innovative Research/Human PAI-1 NBD labeled at the reactive center loop/IHPAI-P9NBD/0.5mg
Innovative Research/Human PAI-1 NBD labeled at the reactive center loop/IHPAI-P9NBD/1.0mg
版權所有格朗瑞生物科技有限公司，保留所有權利。qq:2601936984 備案:浙ICP備15036797號-1
